Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

 View HTML
0001558370-24-005798.pdf
0001558370-24-005798.rtf
0001558370-24-005798.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-3/A

Pre-effective amendment to an S-3 filing

 View HTML
0001558370-16-006734.pdf
0001558370-16-006734.rtf
0001558370-16-006734.xls
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-15-001077.pdf
0001558370-15-001077.rtf
0001558370-15-001077.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-15-001584.pdf
0001558370-15-001584.rtf
0001558370-15-001584.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-15-002529.pdf
0001558370-15-002529.rtf
0001558370-15-002529.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-16-005818.pdf
0001558370-16-005818.rtf
0001558370-16-005818.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-16-007817.pdf
0001558370-16-007817.rtf
0001558370-16-007817.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-16-009951.pdf
0001558370-16-009951.rtf
0001558370-16-009951.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-17-003397.pdf
0001558370-17-003397.rtf
0001558370-17-003397.xls
EX-101.INS - EX-101.INS
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-17-005728.pdf
0001558370-17-005728.rtf
0001558370-17-005728.xls
EX-101.INS - EX-101.INS